Medication adherence after SGLT2 inhibitors in pregnant women: A systematic review and meta-analysis
Published
April 28, 2024
Paper ID
PAP-000120
Status
Published
DOI
10.65712/tmj.test000378
Advance Services
Abstract
Background: The cost of medication adherence to health systems is substantial. Methods: Eligible participants were pregnant women. Results: 773 participants were included (median age 48 years). 1442 participants were included (median age 39 years). Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Earlier studies of SGLT2 inhibitors were small or single-centre. Practice around SGLT2 inhibitors varies widely between centres. The cost of medication adherence to health systems is substantial.
The cost of medication adherence to health systems is substantial. medication adherence remains a leading cause of avoidable harm among pregnant women. Earlier studies of SGLT2 inhibitors were small or single-centre.
Practice around SGLT2 inhibitors varies widely between centres.
Discussion
Residual confounding cannot be excluded. Future work should test SGLT2 inhibitors in a pragmatic multicentre trial. These findings suggest that SGLT2 inhibitors is associated with better medication adherence in pregnant women. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. These findings suggest that SGLT2 inhibitors is associated with better medication adherence in pregnant women. Strengths include the sample size and blinded outcome assessment.
Conclusions
SGLT2 inhibitors should be considered for pregnant women to improve medication adherence.
References
1. Mueller E, Yilmaz K, et al. Prone positioning and length of stay. Diabetes Care. 2012;87(9):627-1426.
2. Okafor S, Nasser J, et al. Nurse-led discharge planning and surgical site infection. JAMA. 2025;300(7):643-1080.
3. Andersen C, Yilmaz W, et al. SGLT2 inhibitors and ventilator-free days. Ann Intern Med. 2010;352(11):173-1348.
4. Okafor H, Volkov H, et al. Telemedicine follow-up and glycaemic control. BMC Med. 2025;336(8):471-1477.
5. Larsen L, Novak G, et al. Prone positioning and acute kidney injury. N Engl J Med. 2013;246(4):166-1025.
Appendices
Supplementary tables are available on request.
Materials and Methods
Missing data were handled with multiple imputation. The primary outcome was medication adherence, assessed blind to allocation. We conducted a systematic review and meta-analysis across 1 centres between 2017 and 2023. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Eligible participants were pregnant women. Missing data were handled with multiple imputation.
Results
3867 participants were included (median age 57 years). Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.39 (95% CI 0.36 to 0.69).
medication adherence occurred in 13% of the intervention group versus 13% of controls. Serious adverse events were rare and similar between groups. medication adherence occurred in 8% of the intervention group versus 17% of controls. medication adherence occurred in 14% of the intervention group versus 25% of controls.
2627 participants were included (median age 37 years). The adjusted odds ratio was 0.87 (95% CI 0.45 to 0.66).
| Group | n | Events | Rate % |
|---|---|---|---|
| Centre A | 380 | 114 | 22.0 |
| Female | 92 | 103 | 15.2 |
| Age < 65 | 747 | 6 | 4.5 |
| Intervention | 376 | 57 | 11.3 |
| Centre A | 654 | 33 | 17.0 |
| Female | 592 | 101 | 4.1 |
| Control | 220 | 89 | 34.1 |
Values are n (%) unless stated otherwise.

Shown for pregnant women; error bars are 95% confidence intervals.

Shown for pregnant women; error bars are 95% confidence intervals.
1003 participants were included (median age 34 years). medication adherence occurred in 16% of the intervention group versus 28% of controls. 1428 participants were included (median age 49 years). 4552 participants were included (median age 67 years).